1.0499
0.0299 (2.93%)
0.0299 (2.93%)
Upgrade to Real-Time
Afterhours
Low
0.632
High
3.50
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Salarius Pharmaceuticals Inc | SLRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.0299 | 2.93% | 1.0499 | 16:36:41 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.03 | 1.02 | 1.07 | 1.04 | 1.02 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.04 | 1.05 | 0.01 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,918 | 1,203,802 | $ 1.04 | $ 1,251,977 | 2,721,707 | 0.632 - 3.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:36:41 | 50 | $ 1.05 | USD |
Salarius Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 47.01M | 44.77M | 44.63M | $ 5.23M | $ - | -0.55 | -2.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 19.39k | 2.40% |
Salarius Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SLRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.22 | 1.23 | 1.00 | 1.09 | 1,645,585 | -0.1701 | -13.94% |
| 1 Month | 1.22 | 1.49 | 1.00 | 1.23 | 3,592,063 | -0.1701 | -13.94% |
| 3 Months | 1.40 | 1.55 | 1.00 | 1.24 | 1,664,807 | -0.3501 | -25.01% |
| 6 Months | 0.86 | 3.50 | 0.8058 | 1.72 | 2,187,403 | 0.1899 | 22.08% |
| 1 Year | 1.52 | 3.50 | 0.632 | 1.61 | 1,277,148 | -0.4701 | -30.93% |
| 3 Years | 11.55 | 14.8154 | 0.13 | 1.61 | 802,773 | -10.50 | -90.91% |
| 5 Years | 11.55 | 14.8154 | 0.13 | 1.61 | 802,773 | -10.50 | -90.91% |
Salarius Pharmaceuticals Description
| Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing effective treatments for cancers with high, unmet medical need. It is engaged in developing treatments for cancers caused by dysregulated gene expression. The company's lead epigenetic-based technology, seclidemstat (SP-2577) is a small molecule, administered orally, that inhibits the epigenetic enzyme lysine specific demethylase 1. |
